The Complex Interaction Of Poverty, Pollution, Health Status

Major disparities exist between the health status of the overall population of the United States and that of its socioeconomically disadvantaged groups, especially African Americans, Hispanics/Latinos, American Indians, and Pacific Islanders, as shown by health survey analyses (H. Freeman, Journal of the National Cancer Institute, 83:525-7, 1991; C. Baquet et al., J. Natl. Cancer Inst., 83:551-7, 1991; M. Angell, New England Journal of Medicine, 329:126-7, 1993). The most striking health discr

Written byKenneth Olden
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Major disparities exist between the health status of the overall population of the United States and that of its socioeconomically disadvantaged groups, especially African Americans, Hispanics/Latinos, American Indians, and Pacific Islanders, as shown by health survey analyses (H. Freeman, Journal of the National Cancer Institute, 83:525-7, 1991; C. Baquet et al., J. Natl. Cancer Inst., 83:551-7, 1991; M. Angell, New England Journal of Medicine, 329:126-7, 1993). The most striking health discrepancies involve shorter life expectancy as well as higher rates of cancer, birth defects, infant mortality, asthma, diabetes, and cardiovascular disease.

A recent county-by-county study of the U.S. population demonstrated that life expectancy was decreased by as much as 15 years in those communities experiencing the most severe poverty (C. Murray et al., U.S. County by County Pattern of Mortality by Race, 1965-1994, Harvard Center for Population and Development, 1997). This is particularly disturbing given that such disparities were uncovered ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies